The money will mainly fund research staff and boost the research capability and capacity of partner GP surgeries in Hammersmith & Fulham, Hounslow and Westminster, as well as improving opportunities for primary care staff to develop their careers in research.

Additional investment from NIHR Imperial and University College London Biomedical Research Centres, alongside support from the NIHR North London Regional Research Delivery Network (RRDN), will also allow some of the primary care research units to more efficiently roll-out clinical studies of new medicines, vaccines and medtech innovations. 

Around £80k will also awarded separately to a project that will build on work to improve public and patient engagement for sickle cell disease. 

Reggie Pestininkas, Strategic Development Director for North London RRDN, said: ‘It is great to see all the different ways in which this money will be used to benefit patients and the public. 

‘These projects will help bring research into everyday settings and make it more relevant and accessible to people across our communities.'